| Price | 1,278.00p on 07-04-2026 at 18:50:05 |
|---|---|
| Change | -12.00p -0.93% |
| Buy | 1,284.00p |
| Sell | 1,266.00p |
| Last Trade: | Buy 2.00 at 1,284.00p |
| Day's Volume: | 56,616 |
| Last Close: | 1,278.00p |
| Open: | 1,270.00p |
| ISIN: | GB0000385517 |
| Day's Range | 1,270.00p - 1,294.00p |
| 52wk Range: | 616.00p - 1,295.00p |
| Market Capitalisation: | £254.70m |
| VWAP: | 1,282.72316p |
| Shares in Issue: | 19.93m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Biotech Gwth (BIOG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2 | 1,284.00p | SI Trade |
16:15:58 - 07-Apr-26 |
| Sell* | 2,916 | 1,280.00p | Automatic Execution |
16:06:07 - 07-Apr-26 |
| Sell* | 200 | 1,280.00p | Automatic Execution |
16:06:07 - 07-Apr-26 |
| Buy* | 1 | 1,294.00p | SI Trade |
16:06:02 - 07-Apr-26 |
| Sell* | 1 | 1,278.00p | SI Trade |
16:06:02 - 07-Apr-26 |
| Sell* | 200 | 1,280.00p | Automatic Execution |
16:06:02 - 07-Apr-26 |
| Sell* | 442 | 1,280.00p | Automatic Execution |
16:06:02 - 07-Apr-26 |
| Sell* | 200 | 1,280.00p | Automatic Execution |
16:06:02 - 07-Apr-26 |
| Sell* | 200 | 1,280.00p | Automatic Execution |
16:06:02 - 07-Apr-26 |
| Sell* | 642 | 1,280.00p | Automatic Execution |
16:06:02 - 07-Apr-26 |
Biotech Gwth (BIOG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Apr 2026 1:08 pm | PRN | Net Asset Value(s) |
| 2nd Apr 2026 5:01 pm | PRN | Transaction in Own Shares |
| 2nd Apr 2026 2:23 pm | PRN | Net Asset Value(s) |
| 1st Apr 2026 4:16 pm | PRN | Net Asset Value(s) |
| 1st Apr 2026 9:59 am | PRN | Total Voting Rights |
| 1st Apr 2026 7:00 am | PRN | Biogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc. |
| 31st Mar 2026 12:42 pm | PRN | Net Asset Value(s) |
| 30th Mar 2026 12:43 pm | PRN | Net Asset Value(s) |
| 27th Mar 2026 5:16 pm | PRN | Transaction in Own Shares |
| 27th Mar 2026 1:35 pm | PRN | Net Asset Value(s) |
